Logo image of RCG

RENN FUND INC (RCG) Stock Fundamental Analysis

NYSEARCA:RCG - American Stock Exchange - US7597201059 - Currency: USD

2.77  -0.02 (-0.72%)

Fundamental Rating

3

Overall RCG gets a fundamental rating of 3 out of 10. We evaluated RCG against 222 industry peers in the Capital Markets industry. The financial health of RCG is average, but there are quite some concerns on its profitability. RCG is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

RCG had negative earnings in the past year.
In multiple years RCG reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: RCG reported negative operating cash flow in multiple years.
RCG Yearly Net Income VS EBIT VS OCF VS FCFRCG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M -4M

1.2 Ratios

RCG has a Return On Assets of -6.34%. This is amonst the worse of the industry: RCG underperforms 90.32% of its industry peers.
RCG's Return On Equity of -6.39% is on the low side compared to the rest of the industry. RCG is outperformed by 82.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.06%, RCG is doing worse than 80.65% of the companies in the same industry.
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROIC 0.06%
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A
RCG Yearly ROA, ROE, ROICRCG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 -40 -60

1.3 Margins

Looking at the Operating Margin, with a value of 3.50%, RCG is doing worse than 79.26% of the companies in the same industry.
RCG's Gross Margin of 73.94% is fine compared to the rest of the industry. RCG outperforms 77.88% of its industry peers.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 73.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RCG Yearly Profit, Operating, Gross MarginsRCG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50K -100K -150K -200K

5

2. Health

2.1 Basic Checks

RCG has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, RCG has more shares outstanding
RCG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RCG Yearly Shares OutstandingRCG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M
RCG Yearly Total Debt VS Total AssetsRCG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M

2.2 Solvency

RCG has an Altman-Z score of 98.82. This indicates that RCG is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 98.82, RCG belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
There is no outstanding debt for RCG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 98.82
ROIC/WACCN/A
WACCN/A
RCG Yearly LT Debt VS Equity VS FCFRCG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

2.3 Liquidity

A Current Ratio of 0.77 indicates that RCG may have some problems paying its short term obligations.
RCG has a worse Current ratio (0.77) than 62.21% of its industry peers.
RCG has a Quick Ratio of 0.77. This is a bad value and indicates that RCG is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.77, RCG is not doing good in the industry: 61.75% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77
RCG Yearly Current Assets VS Current LiabilitesRCG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M 2M

4

3. Growth

3.1 Past

RCG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 79.10%, which is quite impressive.
RCG shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.92%.
Measured over the past years, RCG shows a very strong growth in Revenue. The Revenue has been growing by 35.03% on average per year.
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29394.74%
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Sales Q2Q%26.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RCG Yearly Revenue VS EstimatesRCG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 50K 100K 150K 200K 250K
RCG Yearly EPS VS EstimatesRCG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

0

4. Valuation

4.1 Price/Earnings Ratio

RCG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCG Price Earnings VS Forward Price EarningsRCG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCG Per share dataRCG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RCG!.
Industry RankSector Rank
Dividend Yield N/A

RENN FUND INC

NYSEARCA:RCG (1/30/2025, 12:38:22 PM)

2.77

-0.02 (-0.72%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners15.83%
Inst Owner Change0%
Ins Owners6.51%
Ins Owner Change43.16%
Market Cap19.45M
Analysts0
Price TargetN/A
Short Float %0.08%
Short Ratio0.26
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 68.03
P/FCF N/A
P/OCF N/A
P/B 1.41
P/tB 1.41
EV/EBITDA N/A
EPS(TTM)-0.13
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.04
BVpS1.97
TBVpS1.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROCE 0.07%
ROIC 0.06%
ROICexc 0.06%
ROICexgc 0.06%
OM 3.5%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z 98.82
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-29394.74%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Sales Q2Q%26.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y154.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A